Modèle gratuit

    Pharmaceutical Trial: Drug development project with patient recruitment, clinical testing, data analysis, and regulatory submission

    Drug development is a complex, multi-year process requiring meticulous planning and coordination. From initial research through regulatory approval, pharmaceutical trials involve numerous phases, strict timelines, and critical milestones that must be carefully managed to ensure successful outcomes.

    Ce que contient ce modèle

    This template comes with 82 ready-made tasks organized into 22 phases, covering roughly 313 weeks of work. Start dates, durations, and dependencies are already set up — use it as-is or adjust anything to fit your project.

    Pharmaceutical Trial: Drug development project with patient recruitment, clinical testing, data analysis, and regulatory submission
    #Nom de la tâcheDurée
    1
    Preclinical Research and Protocol Development
    180j
    1.1
    Literature Review and Competitive Analysis
    26j
    1.2
    Study Design and Statistical Planning
    33j
    1.3
    Protocol Writing and Documentation
    40j
    1.4
    Investigator's Brochure Development
    27j
    1.5
    Case Report Form Design
    26j
    1.6
    Internal Protocol Review and Approval
    18j
    2
    Regulatory Strategy and Documentation
    89j
    2.1
    Regulatory Strategy Development
    27j
    2.2
    IND Application Preparation
    40j
    2.3
    FDA Pre-IND Meeting Request and Preparation
    18j
    3
    Site Selection and Qualification
    68j
    3.1
    Site Identification and Feasibility Assessment
    19j
    3.2
    Site Qualification Visits
    20j
    3.3
    Principal Investigator Recruitment
    18j
    3.4
    Site Initiation and Training
    5j
    4
    Regulatory Approval Phase
    89j
    4.1
    IND Submission to FDA
    1j
    4.2
    FDA 30-Day Safety Review Period
    32j
    4.3
    IRB/Ethics Committee Submissions
    26j
    4.4
    Regulatory Approval Coordination
    26j
    5
    Phase I Clinical Trial Preparation
    69j
    5.1
    Patient Recruitment Strategy Development
    19j
    5.2
    Clinical Supply Chain Setup
    19j
    5.3
    Data Management System Configuration
    20j
    5.4
    Safety Monitoring Plan Implementation
    5j
    6
    Phase I Trial Execution
    186j
    6.1
    Patient Screening and Enrollment (20-30 patients)
    53j
    6.2
    Dose Escalation Study Conduct
    75j
    6.3
    Safety Data Collection and Monitoring
    28j
    6.4
    Phase I Data Analysis and Report
    24j
    7
    Phase I Safety Review and Go/No-Go Decision
    28j
    7.1
    Data Safety Monitoring Board Review
    14j
    7.2
    Regulatory Consultation for Phase II Design
    8j
    7.3
    Phase II Protocol Amendment Preparation
    4j
    8
    Phase II Clinical Trial Preparation
    73j
    8.1
    Expanded Site Network Development
    26j
    8.2
    Patient Recruitment Scale-Up Planning
    12j
    8.3
    Enhanced Data Collection Systems
    19j
    8.4
    Biomarker and Correlative Studies Setup
    10j
    9
    Phase II Trial Execution
    278j
    9.1
    Patient Enrollment (80-120 patients)
    95j
    9.2
    Treatment Administration and Monitoring
    97j
    9.3
    Interim Efficacy Analysis
    26j
    9.4
    Phase II Completion and Data Lock
    54j
    10
    Phase II Analysis and Regulatory Interaction
    68j
    10.1
    Statistical Analysis and Clinical Study Report
    33j
    10.2
    End of Phase II Meeting Preparation
    12j
    10.3
    FDA End of Phase II Meeting
    5j
    10.4
    Phase III Protocol Development
    12j
    11
    Phase III Clinical Trial Preparation
    89j
    11.1
    Multi-Regional Clinical Trial Strategy
    26j
    11.2
    Global Site Network Establishment
    26j
    11.3
    Regulatory Submissions (International)
    19j
    11.4
    Commercial Manufacturing Scale-Up Coordination
    12j
    12
    Phase III Trial Execution - First Cohort
    188j
    12.1
    Patient Enrollment Wave 1 (300-400 patients)
    87j
    12.2
    Treatment Period and Follow-up Wave 1
    83j
    12.3
    Interim Safety Analysis
    14j
    13
    Phase III Trial Execution - Second Cohort
    179j
    13.1
    Patient Enrollment Wave 2 (300-400 patients)
    88j
    13.2
    Treatment Period and Follow-up Wave 2
    82j
    13.3
    Interim Efficacy Analysis Preparation
    5j
    14
    Data Safety Monitoring Board Reviews
    32j
    14.1
    DSMB Interim Analysis Review
    15j
    14.2
    Regulatory Notification of Interim Results
    8j
    14.3
    Study Continuation/Modification Decision
    5j
    15
    Phase III Trial Completion
    103j
    15.1
    Final Patient Enrollment and Treatment
    54j
    15.2
    Long-term Follow-up Data Collection
    33j
    15.3
    Database Lock and Quality Assurance
    12j
    16
    Final Data Analysis and Statistical Reporting
    83j
    16.1
    Primary Endpoint Statistical Analysis
    26j
    16.2
    Secondary Endpoint and Subgroup Analyses
    26j
    16.3
    Integrated Safety Analysis
    19j
    16.4
    Clinical Study Report Writing
    6j
    17
    Regulatory Submission Preparation
    82j
    17.1
    New Drug Application (NDA) Compilation
    40j
    17.2
    Risk Evaluation and Mitigation Strategy (REMS)
    12j
    17.3
    Prescribing Information Development
    12j
    17.4
    FDA Submission Package Quality Review
    12j
    18
    New Drug Application Submission
    12j
    18.1
    FDA Electronic Common Technical Document Submission
    5j
    18.2
    International Regulatory Submissions (EMA, Health Canada)
    5j
    19
    FDA Review Process Management
    185j
    19.1
    FDA 60-Day Filing Review Period
    61j
    19.2
    FDA Information Requests Response
    40j
    19.3
    Advisory Committee Meeting Preparation
    40j
    19.4
    Advisory Committee Meeting
    5j
    19.5
    FDA Final Review and PDUFA Date Response
    31j
    20
    Post-Marketing Commitments and Launch Preparation
    70j
    20.1
    Post-Marketing Study Protocol Development
    22j
    20.2
    Phase IV Clinical Trial Infrastructure Setup
    22j
    20.3
    Commercial Launch Strategy Implementation
    22j
    21
    Quality Assurance and Regulatory Compliance
    2189j
    21.1
    Good Clinical Practice (GCP) Monitoring
    2117j
    21.2
    Clinical Trial Audits and Inspections
    1774j
    21.3
    Pharmacovigilance and Safety Reporting
    1684j
    21.4
    Regulatory Intelligence and Guidance Monitoring
    2189j
    22
    Project Management and Communication
    2189j
    22.1
    Stakeholder Communication and Reporting
    2189j
    22.2
    Risk Management and Mitigation Planning
    2189j
    22.3
    Budget Management and Resource Allocation
    2189j
    22.4
    Timeline Management and Critical Path Analysis
    2189j
    82 tâches·22 phases·~313 semaines
    Prêt à personnaliser

    Understanding Pharmaceutical Drug Development

    Pharmaceutical drug development is one of the most complex and regulated processes in modern business, requiring years of careful planning, execution, and oversight. From initial compound discovery to final regulatory approval, pharmaceutical companies must navigate through multiple phases of clinical trials, each with its own unique challenges, timelines, and regulatory requirements. The entire process can take anywhere from 10-15 years and cost billions of dollars, making effective project management absolutely critical for success.

    Key Phases of Pharmaceutical Trials

    A comprehensive pharmaceutical trial involves several distinct phases that must be executed in sequence, with each phase building upon the results of the previous one:

    • Preclinical Research. This initial phase involves laboratory testing and animal studies to evaluate the safety and efficacy of potential drug compounds. Researchers must demonstrate that the drug shows promise and doesn't cause significant harm before moving to human trials.
    • Phase I Trials. The first human testing phase focuses primarily on safety, involving small groups of healthy volunteers or patients to determine safe dosage ranges and identify side effects.
    • Phase II Trials. These trials expand testing to larger groups to evaluate both safety and effectiveness, often comparing the new drug to existing treatments or placebos.
    • Phase III Trials. Large-scale studies involving hundreds or thousands of participants across multiple locations to confirm effectiveness and monitor adverse reactions.
    • Regulatory Submission. Compilation and submission of all trial data to regulatory agencies like the FDA for approval review.

    Critical Components of Trial Management

    Successfully managing a pharmaceutical trial requires coordination of numerous complex elements. Patient recruitment is often one of the most challenging aspects, requiring careful screening processes to ensure participants meet specific criteria while maintaining ethical standards. Clinical testing must follow strict protocols and good clinical practice (GCP) guidelines to ensure data integrity and patient safety. Data analysis involves sophisticated statistical methods and must comply with regulatory requirements for transparency and accuracy.

    Regulatory Compliance and Documentation

    Throughout the entire process, regulatory compliance is paramount. Every aspect of the trial must be thoroughly documented, from patient consent forms to adverse event reports. Regulatory agencies require detailed protocols, safety monitoring plans, and regular progress reports. The final regulatory submission package can contain hundreds of thousands of pages of documentation, all of which must be meticulously organized and cross-referenced.

    Why Use Gantt Charts for Pharmaceutical Trials?

    The complexity and regulatory requirements of pharmaceutical trials make them ideal candidates for Gantt chart project management. With Instagantt, pharmaceutical companies can visualize dependencies between trial phases, track critical milestones, and ensure that all regulatory deadlines are met. The software allows teams to coordinate across multiple clinical sites, manage resource allocation, and maintain clear visibility into project progress.

    Key benefits include tracking patient enrollment progress against targets, managing regulatory submission timelines, coordinating between clinical research organizations (CROs) and internal teams, and ensuring compliance with safety monitoring requirements. Visual project management becomes essential when dealing with the intricate timelines and dependencies inherent in pharmaceutical development.

    Start planning your pharmaceutical trial with precision and confidence using Instagantt's comprehensive project management capabilities.

    Prêt à l'emploi

    Commencez à travailler immédiatement avec ce modèle prédéfini. Aucune configuration requise.

    Conçu pour les équipes

    Partagez avec votre équipe, attribuez des tâches et collaborez en temps réel.

    Entièrement personnalisable

    Adaptez chaque tâche, chronologie et dépendance à votre flux de travail.

    Foire aux questions

    Que contient le modèle Pharmaceutical Trial: Drug development project with patient recruitment, clinical testing, data analysis, and regulatory submission ?

    Le modèle comprend 111 tâches prêtes à l'emploi organisées en 22 phases, avec des dates, des durées et des dépendances modifiables, de sorte que le planning se mette à jour automatiquement en cas de modification.

    Ce modèle de diagramme de Gantt est-il gratuit ?

    Oui. Vous pouvez ouvrir le modèle, explorer le plan complet et commencer à le personnaliser avec un compte Instagantt gratuit — l'offre gratuite couvre jusqu'à 3 projets sans limite de durée.

    Puis-je personnaliser les tâches, les dates et les phases ?

    Oui, tout est modifiable. Renommez ou supprimez des tâches, faites glisser les barres pour modifier les dates, ajoutez des dépendances et des jalons, attribuez des responsables et ajoutez de nouvelles phases. Les tâches dépendantes sont automatiquement reprogrammées lorsque vous déplacez un élément en amont.

    Puis-je partager le plan avec des personnes qui n'ont pas Instagantt ?

    Oui. Chaque projet peut générer un lien d'instantané public en lecture seule que les parties prenantes et les clients peuvent ouvrir dans un navigateur sans compte, ainsi que des exports PDF et image pour les rapports et les présentations.

    Commencez la planification avec ce modèle

    Utilisez ce modèle de diagramme de Gantt pour lancer votre projet en quelques minutes. Personnalisez-le pour répondre précisément à vos besoins.

    Intégration Asana Slack GitHub